Company: IMNN
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022120
Chunk: 8

Company: Imunon, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 8
Chunk 8
---
 Company comply with the applicable listing requirements under
NASDAQ Marketplace Rules, which requirements include, among others, a minimum bid price of at least $1.00 per share.

Immediately
prior to the reverse stock split, the Company had 31,828,447 shares of common stock outstanding which consolidated into 2,121,942 shares
of the Company’s common stock. No fractional shares were issued in connection with the reverse stock split. All fractional shares
were rounded up to the nearest whole share. The reverse stock split did not impact the total authorized number of shares of common
or preferred stock or the par value thereof. The number of outstanding options, stock awards and warrants were adjusted accordingly,
with outstanding options and stock awards being reduced from approximately 1.9 million to approximately 0.1 million and outstanding warrants
being reduced from approximately 12.7 million to approximately 0.8 million.

Increase
to Authorized Shares

At
the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of the Company held on July 11, 2025, upon the recommendation
of the Company’s board of directors, the Company’s stockholders voted on and approved an amendment to the Company’s
Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 112,500,000 shares to 350,000,000
shares, and to make a corresponding change to the number of authorized shares of capital stock. Such amendment became effective on July
11, 2025 upon filing with the Secretary of State of the State of Delaware.

    12

Stock
Dividend

On
July 28, 2025, the Company announced that the Company’s Board of Directors approved a 15% stock dividend, 0.15 shares of common
stock (the “Stock Dividend”) per share of the Company’s issued and outstanding shares of common stock and per each
common stock equivalent with dividend rights.

The
Board of Directors fixed August 7, 2025 as the record date (the “Record Date”) for the Stock Dividend, and the Stock Dividend
was issued on August 21, 2025 to stockholders of record as of the Record Date.

The number of outstanding warrants were adjusted accordingly, with outstanding warrants increasing from approximately
0.8 million to approximately 1.0 million.

At
the Market Offering Agreement

On
May 15, 2024, the Company amended the At the Market Offering Agreement, dated as